Interestingly, the oncogenicity of GOLPH3 seems to be mediated by a mechanism that involves enhanced signaling through the mammalian target of rapamycin (mTOR), conferring cancer cells hypersensitivity to rapamycin [3]. Here, GOLPH3 is linked to cancer.